Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Davita Healthcare Partners Inc (DVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,828,860
  • Shares Outstanding, K 166,000
  • Annual Sales, $ 11,405 M
  • Annual Income, $ 159,390 K
  • 36-Month Beta 1.31
  • Price/Sales 0.86
  • Price/Cash Flow 8.12
  • Price/Book 2.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.95
  • Number of Estimates 6
  • High Estimate 1.02
  • Low Estimate 0.90
  • Prior Year 1.05
  • Growth Rate Est. (year over year) -9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.81 +8.03%
on 02/14/19
59.97 -1.27%
on 02/21/19
+1.84 (+3.21%)
since 01/18/19
3-Month
48.25 +22.72%
on 12/26/18
66.74 -11.28%
on 12/03/18
-0.42 (-0.70%)
since 11/21/18
52-Week
48.25 +22.72%
on 12/26/18
79.11 -25.15%
on 11/07/18
-13.34 (-18.39%)
since 02/21/18

Most Recent Stories

More News
New Strong Sell Stocks for February 19th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

FOSL : 15.15 (+1.81%)
ATVI : 41.90 (-2.06%)
L : 47.53 (+0.19%)
FOE : 17.88 (-0.06%)
DVA : 59.21 (+0.25%)
Look for Shares of Davita Inc to Potentially Pullback after Yesterday's 1.77% Rise

Davita Inc (NYSE:DVA) traded in a range yesterday that spanned from a low of $59.12 to a high of $59.19. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $58.17...

DVA : 59.21 (+0.25%)
Davita Inc Set to Possibly Pullback After Yesterday's Rally of 1.77%

Davita Inc (NYSE:DVA) traded in a range yesterday that spanned from a low of $59.12 to a high of $59.19. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $58.17...

DVA : 59.21 (+0.25%)
Stock Market News For Feb 14, 2019

Wall Street rally continued in Wednesday buoyed by positive developments on the trade war front.

CPA : 89.33 (-0.63%)
CAT : 138.88 (-1.02%)
TRV : 129.82 (+0.06%)
MRO : 16.68 (-2.34%)
PXD : 136.15 (-3.63%)
DVA : 59.21 (+0.25%)
DaVita (DVA) Q4 Earnings Beat and Revenues Miss Estimates

DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.

VAR : 131.71 (-0.70%)
ANGO : 22.43 (-4.31%)
CNMD : 75.14 (+1.93%)
DVA : 59.21 (+0.25%)
DaVita HealthCare (DVA) Tops Q4 Earnings Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 1.12% and -5.73%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

DVA : 59.21 (+0.25%)
DaVita Inc. 4th Quarter 2018 Results

DaVita Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2018.

DVA : 59.21 (+0.25%)
What's in the Offing for DaVita (DVA) This Earnings Season?

DaVita (DVA) expects headwinds in DaVita Rx, while overseas prospects of the dialysis business look bright.

WMGI : 31.59 (+0.25%)
MDSO : 74.97 (-0.04%)
MASI : 128.81 (+0.02%)
DVA : 59.21 (+0.25%)
Analysts Estimate DaVita HealthCare (DVA) to Report a Decline in Earnings: What to Look Out for

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DVA : 59.21 (+0.25%)
DaVita Inc. Schedules 4th Quarter 2018 Investor Conference Call

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 10 countries around the world, announced today that it will hold its quarterly conference call to discuss...

DVA : 59.21 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade DVA with:

Business Summary

DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups...

See More

Key Turning Points

2nd Resistance Point 60.51
1st Resistance Point 59.86
Last Price 59.21
1st Support Level 58.67
2nd Support Level 58.13

See More

52-Week High 79.11
Fibonacci 61.8% 67.32
Fibonacci 50% 63.68
Fibonacci 38.2% 60.04
Last Price 59.21
52-Week Low 48.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar